Andrew was awarded a Bachelor of Pharmaceutical Science (Hons) from Monash University in 2017. From 2016 to 2018 Andrew worked within the Monash-GSK Centre of Innovation and industrialisation (COI2), HMSTrust Laboratory and, the Medicines Manufacturing Innovation Centre (MMIC) respectively, fulfilling various roles around analytical testing and powder formulation development. Throughout this time, he catered to the analytical and spray drying needs of the Inhaled Oxytocin Project (IOP) before transitioning to a PhD project focusing on the development of a sustainable inhaled drug product for global health applications, supervised by Prof. Michelle McIntosh and Dr. Tori Oliver. Andrew’s PhD project primarily involved in vitro DPI performance characterisation, human factors of inhaler use, powder analysis, spray drying, DoE and mathematical modelling. Andrew aims to submit his thesis in Dec 2021 and is currently seeking further opportunities in the drug development field.